nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine
|
Hoogendoorn, Martine |
|
2019 |
22 |
3 |
p. 313-321 |
artikel |
2 |
Challenges with Forecasting Budget Impact: A Case Study of Six ICER Reports
|
Snider, Julia Thornton |
|
2019 |
22 |
3 |
p. 332-339 |
artikel |
3 |
Choice of Prosthetic Implant Combinations in Total Hip Replacement: Cost-Effectiveness Analysis Using UK and Swedish Hip Joint Registries Data
|
Fawsitt, Christopher G. |
|
2019 |
22 |
3 |
p. 303-312 |
artikel |
4 |
Comparative Effectiveness of Computed Tomography- Versus Ultrasound-Guided Percutaneous Radiofrequency Ablation Among Medicare Patients 65 Years of Age or Older With Hepatocellular Carcinoma
|
Huo, Jinhai |
|
2019 |
22 |
3 |
p. 284-292 |
artikel |
5 |
Copyright/Subscription
|
|
|
2019 |
22 |
3 |
p. A3 |
artikel |
6 |
Correction
|
|
|
2019 |
22 |
3 |
p. 383 |
artikel |
7 |
Correction
|
|
|
2019 |
22 |
3 |
p. 383 |
artikel |
8 |
Correction
|
|
|
2019 |
22 |
3 |
p. 383 |
artikel |
9 |
Cost-Effectiveness of Reclassifying Triptans in Australia: Application of an Economic Evaluation Approach to Regulatory Decisions
|
Parkinson, Bonny |
|
2019 |
22 |
3 |
p. 293-302 |
artikel |
10 |
Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data
|
Holleman, Marscha S. |
|
2019 |
22 |
3 |
p. 322-331 |
artikel |
11 |
Distribution of the EQ-5D-5L Profiles and Values in Three Patient Groups
|
Feng, Yan |
|
2019 |
22 |
3 |
p. 355-361 |
artikel |
12 |
Editorial Board
|
|
|
2019 |
22 |
3 |
p. A4 |
artikel |
13 |
Evaluating Canadians’ Values for Drug Coverage Decision Making
|
Rizzardo, Shirin |
|
2019 |
22 |
3 |
p. 362-369 |
artikel |
14 |
Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report
|
Brazier, John |
|
2019 |
22 |
3 |
p. 267-275 |
artikel |
15 |
Measuring Weight-Specific Quality of Life in Adolescents: An Examination of the Concurrent Validity and Test-Retest Reliability of the WAItE
|
Oluboyede, Yemi |
|
2019 |
22 |
3 |
p. 348-354 |
artikel |
16 |
Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study
|
Bullement, Ash |
|
2019 |
22 |
3 |
p. 276-283 |
artikel |
17 |
Table of Contents
|
|
|
2019 |
22 |
3 |
p. A1-A2 |
artikel |
18 |
Use of Both Qualitative and Quantitative Methods to Estimate Meaningful Change Thresholds for Key Endpoints in Pediatric Asthma Trials
|
Arbuckle, Rob |
|
2019 |
22 |
3 |
p. 340-347 |
artikel |
19 |
Use of Checklists in Reviews of Health Economic Evaluations, 2010 to 2018
|
Watts, Rory D. |
|
2019 |
22 |
3 |
p. 377-382 |
artikel |
20 |
Valuation of Health States Considered to Be Worse Than Death—An Analysis of Composite Time Trade-Off Data From 5 EQ-5D-5L Valuation Studies
|
Gandhi, Mihir |
|
2019 |
22 |
3 |
p. 370-376 |
artikel |